Hiatt, William R.

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery

Peripheral Artery Disease ManagementVascular Procedures and Complications

Cited by 8,191

Rivaroxaban in Peripheral Artery Disease after Revascularization

Bonaca, M. P., Bauersachs, R. M., Anand, S. S., Debus, E. S., Nehler, M. R., Patel, M. R., Fanelli, F., Capell, W. H., Diao, L., Jaeger, N., et al. (2020) · New England Journal of Medicine

Peripheral Artery Disease ManagementAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,045

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Hiatt, W. R., Fowkes, F. G. R., Heizer, G., Berger, J. S., Baumgartner, I., Held, P., Katona, B. G., Mahaffey, K. W., Norgren, L., Jones, W. S., et al. (2017) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 636

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Pradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 319

Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association

Treat-Jacobson, D., McDermott, M. M., Bronas, U. G., Campia, U., Collins, T. C., Criqui, M. H., Gardner, A. W., Hiatt, W. R., Regensteiner, J. G., Rich, K., et al. (2019) · Circulation

Peripheral Artery Disease ManagementCardiovascular and exercise physiology

Cited by 302

The cardiovascular safety of diabetes drugs–insights from the rosiglitazone experience

Hiatt, W. R., Kaul, S., & Smith, R. J. (2013) · New England Journal of Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 204

Cardiovascular Drug Development

Fordyce, C. B., Roe, M. T., Ahmad, T., Libby, P., Borer, J. S., Hiatt, W. R., Bristow, M. R., Packer, M., Wasserman, S. M., Braunstein, N., et al. (2015) · Journal of the American College of Cardiology

Pharmaceutical Economics and PolicyPharmaceutical industry and healthcare

Cited by 202

Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial

Berger, J. S., Katona, B. G., Jones, W. S., Patel, M. R., Norgren, L., Baumgartner, I., Blomster, J., Mahaffey, K. W., Held, P., Millegård, M., et al. (2016) · American Heart Journal

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 47

Pulmonary V̇o2 dynamics during treadmill and arm exercise in peripheral arterial disease

Bauer, T. A., Brass, E. P., Nehler, M., Barstow, T. J., & Hiatt, W. R. (2004) · Journal of Applied Physiology

Cardiovascular and exercise physiologyPeripheral Artery Disease Management

Cited by 41